2020 Speakers

Amy P. Abernethy, MD, PhD is the President of Product Development and Chief Medical Officer at Verily, where she leads teams in the development and delivery of solutions that bridge the gap between clinical research and care.

Before joining Verily, Dr. Abernethy was Principal Deputy Commissioner and Acting Chief Information Officer of the US Food & Drug Administration. Prior roles include serving as CMO/CSO of Flatiron Health and multiple roles at Duke University, where she was Professor of Medicine.

Dr. Abernethy went to the University of Pennsylvania and then Duke University Medical School, and received her PhD from Flinders University in Australia.

Stacey Allaster is an internationally renowned sports and entertainment leader, champion of equality and innovator in the sport of tennis. Currently, Stacey is the United States Tennis Association’s Chief Executive, Professional Tennis, responsible for setting the strategic vision for the USTA’s pro tennis division, including oversight of the US Open, US Open Series, Davis Cup and Fed Cup, the professional developmental pathway for aspiring young Americans and Officiating. Under Stacey's leadership, the USTA leverages professional tennis tournaments and assets to inspire kids and adults to be physically active, play tennis and lead healthy lifestyles.

Previously, Stacey was the Tournament Director of the Canadian Open (now known as the Rogers Cup), where she was the only woman tournament director within the ATP Master Series. In 2006, she was hired as the President of the WTA, and three years later was promoted to Chairman and CEO. During her tenure, Stacey generated $1 billion in revenue, while expanding the global footprint of women’s professional tennis, including a robust Asia-Pacific growth strategy.

Throughout her career, Stacey has been a fierce advocate for equality in women’s sports, playing a lead role in driving prize money growth and securing equal prize money for women at Wimbledon, Roland Garros and WTA major events. Additionally, she has dedicated her personal life and career to inspiring and mentoring the next generation of strong and confident female leaders.

Stacey has been named one of the Top 50 Heroes of Tennis in the past 50 years in Tennis Magazine, the WISE Woman of the Year and a Sports Business Journal Gamechanger. She was also recognized by Forbes as one of the 10 Most Powerful Women in Sports.

Anousheh Ansari is a CEO of the XPRIZE Foundation, the world’s leader in designing and operating incentive competitions to solve humanity’s grand challenges. Ansari, along with her family, sponsored the organization’s first competition, the Ansari XPRIZE, a $10 million competition that ignited a new era for commercial spaceflight.  Since then, she has served on XPRIZE’s Board of Directors.

Prior to being named CEO of XPRIZE, Ansari served as the CEO of Prodea Systems, a leading Internet of Things (IoT) technology firm she co-founded in 2006, and continues to serve as the executive chairwoman. She captured headlines around the world when she embarked upon an 11-day space expedition, accomplishing her childhood dream of becoming the first female private space explorer, first astronaut of Iranian descent, first Muslim woman in space, and fourth private explorer to visit space.

Ansari serves on the World Economic Forum’s (WEF) Global Future Council and has received numerous honors, including the WEF Young Global Leader, Ellis Island Medal of Honor, and STEM Leadership Hall of Fame, among others. She is a UNESCO Good Will Ambassador and serves on the board of Jabil and Peace First, as well as several other not-for-profit organizations focused on STEM education and youth empowerment.

Ansari also co-founded The Billion Dollar Fund for Women, announced at the Tri Hita Karana (THK) Forum on Sustainable Development in Bali, Indonesia, with a goal of investing $1 billion in women-founded companies by 2020.

She published her memoir, My Dream of Stars, to share her life story as inspiration for young women around the world.??Ansari holds a BS in electronics and computer engineering from George Mason University, an MS in electrical engineering from George Washington University; and honorary doctorates from George Mason University, Utah Valley University, and International Space University.

Jeff Arnold is chairman and CEO of Sharecare, a digital health company he founded with Dr. Oz to help each person – no matter where they are in their health journey – build a longer, better life by enabling health transformation at the individual, organizational and community level. Also chairman of Forbes Travel Guide, he was twice named EY Entrepreneur Of The Year – in 1999 for WebMD and 2019 for Sharecare – making him one of a handful of winners in history to receive the award twice.

After concluding a prolific professional cycling career that produced a medal at the 2012 London Olympic Games, eight US national championships, two Pan American gold medals and a world record, Dotsie Bausch has become a powerful influencer for plant-based eating for athletes and non-athletes alike. Named by VegNews in 2019 as one of the top 20 most influential vegans in the world, she utilizes her degree in plant-based nutrition to inform her impassioned messages as an advocate on behalf of humans, planet earth and animals.

Dotsie latest initiative is founding the non-profit Switch4Good. Switch4Good launched in” – early 2018 with a television commercial featuring six Olympians from four different countries and proves that cow’s milk is not part of a high-performance diet.

Bausch is also one of the stars of the film The Game. Changers (http://gamechangersmovie.com), which chronicles the story of the world’s most dangerous myth. Directed by Academy Award winner Louie Psihoyos and executive produced by Oscar winner James Cameron, The Game Changers released to worldwide audiences in October of 2019 and in just one week, became the #1 downloaded film of all time on iTunes.

Long before embodying radiant health and becoming an influential game changer, Bausch struggled for years with severe eating disorders and a recreational drug habit, that combined, led to a suicide attempt. It was during her recovery that she discovered her gift and love for the bike. 

Bausch speaks passionately around the world, spreading her message about the numerous benefits – humane, nutritional and environmental – of plant-based eating. Her popular TEDx Talk, “Olympic Level Compassion,” has garnered over 275,000 views and has been a catalyst of change for thousands of people.

Holly Benson serves as EVP, President and CEO of Health Care Enterprises where she oversees the operations of Community Medical Group, HealthSmart, Interpreta, and USMM. Centene owns all or a portion of each of those companies, and Holly is responsible for ensuring that those companies not only provide quality service to Centene’s health plans but also to external customers and that those companies continue to grow and develop innovative new products and services.

Holly joined Centene in March 2011 as Centene’s Senior Vice President of Health Policy.

Ms. Benson graduated with honors from Dartmouth College and earned her law degree from the University of Florida - College of Law.

Elizabeth H. Bradley, PhD, was named the 11th President of Vassar College in July 2017. Prior to this position, she was on the faculty at Yale for more than twenty years, and was most recently the Brady-Johnson Professor of Grand Strategy and Faculty Director of the Yale Global Health Leadership Institute. She also served as the Head of College for Yale’s Branford College.

Bradley is renowned internationally for her work on quality of hospital care and large-scale health system strengthening efforts within the US and abroad including in China, India, Ethiopia, Liberia, Ghana, Rwanda, and the United Kingdom. In the US, Bradley published the landmark papers that drove national change in the care of patients with heart attacks, and in Ethiopia, Bradley is widely known as a major architect of the system-wide improvements in the quality of health care provided to the 90 million people of that country. Bradley has published more nearly 320 peer-reviewed papers and has co-authored three books including The American Healthcare Paradox: Why Spending More Is Getting Us Less. She is the 2018 recipient of the William B. Graham Prize for Health Services Research, the highest distinction that researchers in the health services field can achieve. Bradley was elected to the National Academy of Medicine in 2017.
 
Bradley graduated phi beta kappa from Harvard in economics magna cum laude, earned an MBA from the University of Chicago, and a PhD in health economics from Yale University. Bradley grew up in New Britain, Connecticut and is married to her husband John with whom she has three adult children.

Dr. Bredesen received his undergraduate degree from Caltech and his medical degree from Duke. He served as Resident and Chief Resident in Neurology at UCSF, then was postdoctoral fellow in the laboratory of Nobel laureate Prof. Stanley Prusiner. He was a faculty member at UCLA from 1989-1994, then was recruited by the Burnham Institute to direct the Program on Aging. In 1998 he became the Founding President and CEO of the Buck Institute for Research on Aging, and Adjunct Professor at UCSF; then in 2013 he returned to UCLA as the Director of the Easton Center for Alzheimer’s Disease Research.

The Bredesen Laboratory studies basic mechanisms underlying the neurodegenerative process, and the translation of this knowledge into effective therapeutics for Alzheimer’s disease and other neurodegenerative conditions, leading to the publication of over 220 research papers. He established the ADDN (Alzheimer’s Drug Development Network) with Dr. Varghese John in 2008, leading to the identification of new classes of therapeutics for Alzheimer’s disease. He and his group developed a new approach to the treatment of Alzheimer’s disease, and this approach led to the discovery of subtypes of Alzheimer’s disease, followed by the first description of reversal of symptoms in patients with MCI and Alzheimer’s disease, with the ReCODE (reversal of cognitive decline) protocol, published in 2014, 2016, and 2018. His book, The End of Alzheimer’s, is a New York Times Bestseller.

John Hope Bryant is an American entrepreneur, thought leader and philanthropic leader. He is referred to as the Conscience of Capitalism by the CEOs of Delta Air Lines, Walmart, and
countless others. Mr. Bryant is the Founder, Chairman, and Chief Executive Officer of Operation
HOPE, Inc. the largest non-profit provider of financial literacy and economic empowerment services in the United States. Bryant is also Chairman and Chief Executive Officer of John Hope Bryant Holdings, Bryant Group Ventures and Executive Chairman of The Promise Homes Company, the largest for-profit minority-controlled owner of institutional-quality, single-family residential rental homes in the U.S.

Bryant has been recognized as an influential leader by many. He has received hundreds of awards and citations for his work, including Oprah Winfrey’s Use Your Life Award, and the John Sherman Award for Excellence in Financial Education from the U.S. Department of Treasury. Bryant has also received the 100 Black Men of America “Chairman’s Award for Economic Empowerment,” he was listed by The Atlanta Business Chronicle’s “2022 Power 100”, named #2 among 100 inspirational leaders on the “Yahoo Finance Empower Role Model list 2022," Georgia Trend’s “100 Most Influential Georgians” in 2022, 2023 and 2024, Atlanta Business Chronicle’s “Most Admired CEOs of 2018,” Atlanta Business Chronicle’s “The Power 100: Most Influential Atlantans in 2020,” American Banker magazine's 2016 “Innovator of the Year,” and one of Time magazine’s “50 Leaders for the Future” in 1994. Bryant received an honorable mention in Inc. Magazine’s “The World’s 10 Top CEOs” an article that spotlights global servant leaders as the visionaries behind some of the most successful organizations.

Five former U.S. presidents have recognized Bryant’s work, and he has served as an advisor to three sitting U.S. presidents from both political parties. In 2008, Bryant inspired President George W. Bush to make financial literacy the official policy of the U.S. federal government.

Bryant is the author of Up from Nothing: The Untold Story of How We (All) Succeed; The Memo: Five Rules for Your Economic Liberation, How the Poor Can Save Capitalism: Rebuilding the Path to the Middle Class, and LOVE LEADERSHIP: The New Way to Lead in a Fear-Based World (Jossey-Bass, 2009).

Howard A. "Skip" Burris III, MD, FASCO, FACP serves as president and chief medical officer of Sarah Cannon, as well as the executive director, drug development for the research institute. He is an associate of Tennessee Oncology, PLLC, where he practices medical oncology.
 

Dr. Barry Byrne is a clinician scientist who is studying a variety of rare diseases withthespecificgoalofdevelopingtherapiesforinheritedmuscle disease. Asa pediatric cardiologist, his focus is on conditions that lead to skeletal muscle weaknessandabnormalitiesinheartandrespiratory function. Hisgrouphas made significant contributions to the understanding and treatment of Pompe disease, a type of neuromuscular disease due to glycogen storage in motor units. Theresearchteamhas beendevelopingnewtherapiesusingAAV-mediatedgene therapy to restore cardiac and skeletal muscle function in DMD, Friedreich’s ataxia, Pompe, and other inherited neuromuscular diseases. His group at the Powell Center has also established a series of new methods for large-scale AAV clinical manufacturing. The work is supported by several NIH and foundation awards.

Dr. Byrne is the Associate Chair of Pediatrics and Director of the University of Florida Powell Center and Child Health Research Institute. He obtained his B.S. degree from Denison University; M.D. and Ph.D. from the University of Illinois; and hecompleted hisPediatricsresidencyandcardiologyfellowshipaswellaspost- doctoral training in Biological Chemistry at the Johns Hopkins Hospital. Following his early career at Hopkins, he joined the University of Florida and is now the Earl and Christy Powell University Chair in Genetics.

In addition to his academic appointments, he serves as the Chief Medical Advisor of the Muscular Dystrophy Association and a member of the TACT committee of TREAT-NMD. He is an advisor to the Pfizer Rare Disease Therapeutic Area Advisory Committee and co-founder of AavantiBio.

Born to a poor immigrant family in New York City, Richard Carmona experienced homelessness, hunger, and health disparities during his youth. The experiences greatly sensitized him to the relationships among culture, health, education and economic status and ultimately shaped his future.

After dropping out of high school, Dr. Carmona enlisted in the U.S. Army in 1967 where he received a GED. By the time he left active duty, he was a Special Forces, combat-decorated Vietnam veteran. He then pursued a college degree and entered medical school at the University of California – San Francisco where he won the prestigious Gold Cane award as the top graduate.

Dr. Carmona became a surgeon with a sub-specialty in trauma, burns and critical care and was recruited to Tucson to establish the first trauma system in southern Arizona which he did successfully. Later, while working full time as a hospital and health system CEO, he earned a master’s degree in public health policy and administration at the University of Arizona.

Dr. Carmona has served for over 34 years with the Pima County Sheriff’s Department in Tucson, including as deputy sheriff, detective, SWAT team leader and department surgeon. He is one of the most highly decorated police officers in Arizona, and his numerous awards include the National Top Cop Award, the National SWAT Officer of the Year, and the National Tactical EMS Award. Dr. Carmona is a nationally recognized SWAT expert and has published extensively on SWAT training and tactics, forensics, and tactical emergency medical support. Dr. Carmona has also served as a medical director of police and fire departments and is a fully qualified peace officer with expertise in special operations and emergency preparedness, including weapons of mass destruction.

In 2006 Vice Admiral Carmona successfully completed the statutory four-year term as Surgeon General and was named vice chairman of Canyon Ranch, CEO of the health division and president of the Canyon Ranch Institute. Dr. Carmona continues his Canyon Ranch leadership role as the Chief of Health Innovations. He also serves on several public corporate boards and works with private equity and venture capital firms to identify emerging science and technology to translate to market for economic and public benefit.

Gloria Caulfield leads health and wellness strategy and planning for the Lake Nona Institute. Gloria is passionate about identifying partners who are skillful at collaboration and have the desire to innovate solutions that have the potential to move the needle on community health and wellness.

Toby Cosgrove, MD, is former CEO and current Executive Advisor of Cleveland Clinic. He is Strategic Advisor to Care Centrix, Senior Advisor of Innova Health Partners, and is Member of the Board of Directors of Cleveland Clinic Abu Dhabi, American Well, Hims & Hers and View. He worked for Google Cloud and currently is an advisor for several healthcare organizations. As an expert on health issues, he is a frequent commentator in national and international media.
As CEO and President of Cleveland Clinic from 2004 through 2017, he led the $8 billion organization to new heights of achievement and efficiency, seeing it ranked the #2 hospital in America (U.S. News). In his role as Executive Advisor, he is working with Cleveland Clinic leadership on strategies for national and international growth.
Dr. Cosgrove graduated from Williams College and the University of Virginia School of Medicine. He trained at Massachusetts General Hospital and Brook General Hospital in London. In 1967, he was a surgeon in the U.S. Air Force, earning a Bronze Star.

Dr. Cosgrove joined Cleveland Clinic in 1975, and chaired the Department of Thoracic and Cardiovascular surgery from 1989 to 2004. He performed over 22,000 operations and earned an international reputation in valve repair. He holds 30 patents for medical innovations. As CEO from 2004 to 2017, he reorganized services, improved outcomes and patient experience, and strengthened the organization’s finances.

He is a member of the National Academy of Medicine, and a Fellow of the National Academy of Inventors. In 2016, he was a Fortune Businessperson of the Year (No. 14). Three successive presidents of the United States have consulted him on healthcare issues.

John F. Crowley is the Executive Chairman and founding CEO of Amicus Therapeutics, a biotechnology company focused on the development of treatments for rare genetic diseases. Crowley also currently serves as Vice Chair of the Biotechnology Innovation Organization (BIO). Crowley’s involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal neuromuscular disorder. In his drive to find a cure, he became an entrepreneur as the Co-founder, President and CEO of Novazyme Pharmaceuticals, which he credits as ultimately saving his children’s lives. The 2010 movie, Extraordinary Measures, is inspired by the Crowley family journey. Crowley served as a commissioned officer in the U.S. Navy Reserve from 2005-2016, and is a veteran of the global war on terrorism, with service in Afghanistan. He graduated with a B.S. in Foreign Service from Georgetown University and earned a J.D. from the University of Notre Dame Law School and an M.B.A. from Harvard Business School. He was awarded a Doctor of Laws Degree from Notre Dame. The Crowley family received the Family Exemplar Award from Notre Dame. Crowley serves as a member of the Board of Directors of Intellia Therapeutics, Inc. and Entrada Therapeutics, Inc. He is the former National Chairman of the Make-A-Wish Foundation of America and is a Henry Crown Fellow at the Aspen Institute. In 2023, he was inducted as a member of the Horatio Alger Association.

Karen Dale is the CEO for AmeriHealth Caritas District of Columbia, which serves more than 120,000 members.  Guided by the organization's mission and values as well as the strategies of innovation and collaboration, she is implementing population health approaches, leading policy change and creating a more human-centered system of care.  Her career includes working in public health, and hospital systems.

Lynda Deakin is a partner and managing director at IDEO. With over 20 years of experience in human centered design, she focuses on driving change in the food and health systems to enable better care and choices for people and the planet. Lynda works across the food and healthcare industries and uses design as a tool to help individuals, organizations, and society establish healthier, more sustainable behaviors. She has spoken on this topic and more at the Danone 100 Years event and the Culinary Institute of America and MIT Media Lab’s ReThink Food conference, and served as a judge for the Basque Culinary World Prize.

Lynda’s empathic approach and charismatic leadership enables clients to address customer and patient desires and tackle a wide variety of challenges, from embracing the circular economy of food and bringing healthcare to the underserved to transforming food at scale and building disruptive new health ventures. Lynda has collaborated with large companies and organizations as well as smaller startups and foundations that are on a mission to reshape the future of food and health, including Revolution Foods, Nestle, The J.M. Smucker Company, Habit, Del Monte Foods, and the Basque Culinary Center.

Lord Michael Dobbs is Britain’s foremost parliamentary novelist and an active member of the House of Lords. He is best known for writing House of Cards, now a global TV hit with Netflix, based on his experience as Margaret Thatcher’s chief of staff. He has written award-winning novels about Winston Churchill and has a doctorate in international affairs.

Victor J. Dzau is the President of the US National Academy of Medicine (NAM). In addition, he serves as Vice Chair of the US National Research Council. He is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System.

Dr. Emmeline Edwards is director of the Division of Extramural Research of the National Center for Complementary and Integrative Health (NCCIH). In that capacity, she is responsible for development of scientific programs or areas of science that fulfill NCCIH's mission as well as planning, implementation and policy. NCCIH is one of 27 components of the National Institutes of Health (NIH), with a mission to define, through rigorous scientific investigation, the usefulness and safety of complementary and alternative medicine interventions and their roles in improving health and health care.

Before coming to NIH, Dr. Edwards earned her Ph.D. in Neurochemistry from Forham University, did postdoctoral research in behavioral pharmacology and neuroscience at the State University of New York, and was a tenured Associate Professor in the Department of Pharmacology at the University of Maryland. Her research there focused on the neural mechanisms of complex behaviors and characterization of a genetic model of affective disorders. She also served as Chair of the Graduate Studies and Research Committee and Member of the Dean's Executive Council at the University of Maryland.

Currently, Dr. Edwards is also Chair of Women World in Neuroscience (WWN), an independent mentoring and networking organization, with the primary mission of identifying, promoting and implementing mentoring and networking opportunities for women neuroscientists across the world.

Charlie Engle is a global ultra-endurance athlete and the founder of the 5.8 Global Adventure Series, one of the most ambitious expeditions in modern history, trekking from the lowest to the highest points on all seven continents. He is also one of the most accomplished ultramarathon runners in the world, having placed in hundreds of races in dozens of countries.

His incredible athletic ability was profiled in the film, Running the Sahara, narrated by Matt Damon. The documentary highlighted his historic, record-setting journey with his two teammates across the world’s largest desert, running more than two marathons a day for 111 consecutive days, for a total of 4,500 miles. Charlie’s transcontinental run through deep sand and politically unstable countries remains one of the premier accomplishments in the ultra-endurance and adventure sports worlds. After crossing the Sahara and seeing the global water crisis first-hand, Charlie raised more than $6 million for clean water projects in Africa and helped establish an organization called H20Africa, now known as Water.org, one of the largest water nonprofit in the world.

Charlie’s memoir, Running Man, became a bestseller shortly after it was published in 2016. While the book details his inspiring life story, it is about more than just running. It is about facing demons, overcoming impossible odds, keeping your sense of humor and discovering the redemptive power of putting one foot in front of the other, even when you feel like you can’t keep going.

His motivation to run and tackle extreme adventures stems from his battle with addiction to drugs and alcohol. Charlie has been in recovery since July 23, 1992, and he credits a large part of his recovery to the purposeful devotion and emotional release he experiences while running. He has said that “Drugs and alcohol were my way out. Running was my way through.”

Charlie is a dynamic speaker who has enthralled audiences around the world, from keynotes at the Boston Marathon and Google to the National Geographic Society, the United Nations and the deck of a nuclear-class U.S. Naval aircraft carrier.

He’s been featured in the New York Times, National Geographic Weekend, Outside, Runner’s World, NPR’s All Things Considered, Men’s Journal, and The Tonight Show with Jay Leno. He lives with his wife, Astacianna Hatcher, in Durham, North Carolina.

Chris Evert, one of the most accomplished tennis players in history, burst onto the national tennis scene at the age of 15, and a year later made the 1971 US Open semifinals in her first Grand Slam event. Evert won 18 major singles championships (two Australian Open, three Wimbledon, and a record six US Open and seven French Open titles), winning at least one each year for 13 consecutive years (1974-1986). She retired in 1989 with 157 singles titles overall, and a career win-loss record of 1,309-146 (.900), the best of any professional player in history.

She was voted the AP Female Athlete of the Year four times and in 1985 was voted the Greatest Woman Athlete of the Last 25 Years by the Women’s Sports Foundation. She was a unanimous selection to the Tennis Hall of Fame in 1995.

In 2019, the USTA Foundation, the national charitable arm of the United States Tennis Association (USTA), appointed Evert as Chair of the USTA Foundation’s Board of Directors. In this role, Evert serves as the Foundation’s spokesperson and ambassador to promote its mission and increase the impact of its national outreach efforts to under-resourced youth.

Evert joined ESPN in 2011 as an analyst, and has since covered all four Grand Slam events – including ESPN’s start-to-finish coverage of three Grand Slams – the Australian Open, Wimbledon and the US Open. She also worked as an analyst for NBC for 10 years.

Evert operates a tennis academy bearing her name in Boca Raton, Fla., and writes a column for Tennis Magazine.

Renée Fleming is one of the most highly acclaimed singers of our time, performing on the stages of the world’s great opera houses and concert halls. Honored with five Grammy® awards and the US National Medal of Arts, she has sung for momentous occasions from the Nobel Peace Prize ceremony to the Super Bowl. A Goodwill Ambassador for Arts and Health for the World Health Organization, she was awarded the prestigious Kennedy Center Honor in December.
Renée’s anthology, Music and Mind: Harnessing the Arts for Health and Wellness, will be published by Viking in April. A leading advocate for research at the intersection of arts, health, and neuroscience, Renée launched the first ongoing collaboration between The Kennedy Center for the Performing Arts and the US National Institutes of Health. She has presented her program Music and Mind in more than fifty cities around the world, and in November, she was awarded Harvard’s David Mahoney Neuroscience Prize. She is a founding advisor for major initiatives including the Sound Health Network at the University of California San Francisco and the NeuroArts Blueprint, a project of Johns Hopkins University and the Aspen Institute.
Renée’s recording Voice of Nature: The Anthropocene won the 2023 Grammy Award for Best Classical Solo Vocal Album. Her current and upcoming concerts inspired by the album include an original film by the National Geographic Society created to reflect the musical selections. Recent opera performances include starring in the world premiere staging of The Hours, a new opera based on the Pulitzer Prize-winning novel and award-winning film, at the Metropolitan Opera, and a role debut as Pat Nixon in a new production of Nixon in China at the Opéra de Paris.

In addition to directing SongStudio at Carnegie Hall, Renée is Co-Artistic Director of the Aspen Opera Theater and VocalARTS at the Aspen Music Festival and School, and Advisor for Special Projects at the Los Angeles Opera. Other awards include the 2023 Annenberg Award for Diplomacy through the Arts, the 2023 Crystal Award from the World Economic Forum, the Fulbright Lifetime Achievement Medal, the Order of Merit from Germany, and the French Ordre national de la Légion d’honneur. She holds honorary doctorates from eight leading universities. www.reneefleming.com

Energy, fashion, and talent collide every time Chloe Flower sits behind her piano. In February, Chloe’s performance at the 2019 Grammy Awards with Cardi B was a viral sensation. On a mission to make classical music more accessible, Chloe was recently featured on The Today Show and CNN. Her single “Get What U Get” shot to Number 1 on the classical charts.

Sandro Galea, a physician, epidemiologist, and author, is dean and Robert A. Knox Professor at Boston University School of Public Health. He has published 18 books and over 850 peer-review journal articles. He has been listed as one of the world’s most widely cited scholars. He has two children and is a devoted Juventus soccer fan. 

Pat Geraghty is President and Chief Executive Officer of GuideWell, a $26 billion mutual insurance holding company headquartered in Jacksonville, Fla. A mission-driven health solutions enterprise, GuideWell is the parent to a family of forward-thinking companies focused on transforming health care.

GuideWell comprises Florida Blue, Florida’s Blue Cross Blue Shield plan and leading health insurance company in Florida; Triple-S Management, Puerto Rico’s Blue Cross Blue Shield plan and leading health care services company in Puerto Rico; GuideWell Health, a portfolio of clinical delivery organizations; GuideWell Venture Group, a portfolio of companies, including PopHealthCare, focused on creating human-first and innovative health solutions for health plans; GuideWell Source, a provider of administrative services to state and federal health care programs; and WebTPA, a market leading administrator of self-funded employer health plans. GuideWell serves more than 46 million people across 45 states, Puerto Rico and the U.S. Virgin Islands, including more than 6 million individuals in Florida.

Geraghty was the architect of the strategic restructuring that created GuideWell from the foundation of a more than 75-year-old health insurance company, transforming it into a health solutions organization at the forefront of reimagining the future of health.

Geraghty is considered an expert voice on a range of health care topics including health care reform, next-generation payment strategies, innovation in health care and the benefits of wellness and prevention programming. He is frequently sought after for his insights on important health care policy matters in Washington, D.C. and Tallahassee, Fla.

He is a member of the Florida Council of 100 and serves on the boards of the Blue Cross Blue Shield Association, including chair of its Health Policy & Advocacy Committee, National Institute of Health Care Management; America’s Health Insurance Plans; and Tampa Electric Co. His work with United Way, MaliVai Washington Youth Foundation and American Cancer Society are also among his most important commitments.

Geraghty holds a Bachelor of Arts degree from Colgate University and a Doctor of Humane Letters, honoris causa, degree from Florida Southern College. He also has completed executive education programs at Harvard University School of Public Health and the Wharton School at the University of Pennsylvania.

Admiral Brett Giroir is the 16th Assistant Secretary for Health. He serves as the Secretary’s principal public health and science advisor, senior adviser for HRSA, CDC, and SAMHSA and chief opioid policy adviser. He also oversees the Office of the Surgeon General and the U.S. Public Health Service Commissioned Corps.  

Guru Gowrappan is CEO of Verizon Media, a powerhouse of trusted media and technology brands, including Yahoo, HuffPost, and TechCrunch. Prior to his role at Verizon, he was Global Managing Director of Alibaba where he where he focused on international expansion for key consumer and enterprise products. He has ~20 years of global industry experience building products, operationalizing and scaling businesses across mobile ecosystem and platforms, including commerce & payments, media & gaming, search & utilities, ad products. He has held a breadth of including leadership roles (CEO, COO, CPO) at companies such as Quixey, Zynga, and Overture. He is also a co-founder of two Indian startups. He has an M.S. in computer science from USC and was in the Business bridge program from the Tuck School of Business at Dartmouth.

Dr. Staci Gruber is the Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School. Dr. Gruber’s clinical research focuses on the application of neurocognitive models and brain imaging to better characterize risk factors for substance abuse and psychiatric conditions. She has been studying the impact of cannabis on the brain for over two decades using neurocognitive, clinical and diagnostic assessments and multimodal brain imaging techniques.

Her work examining the etiologic bases of neural models of dysfunction in cannabis-using adolescents and adults has been published in numerous peer reviewed journals and been the basis of national and international symposia, documentaries, news stories and press conferences, including features in the New York Times, NPR, and CNN’s documentary series “WEED” with Dr. Sanjay Gupta. Her ongoing initiative to educate policymakers, judges, attorneys and the general public about the neurobiologic differences between adults and adolescents as well as additional factors that contribute to the impact of cannabis on the brain have had both local and national impact on policy formation. In fact, Dr. Gruber recently testified at the Senate Caucus on International Narcotics Control hearing entitled, “Marijuana and America’s Health: Questions and Issues for Policy Makers.”

Dr. Gruber recognized the importance of examining the impact of medical cannabis use on the brain, as there are many inherent differences between recreational and medical cannabis users. Accordingly, in 2014, Dr. Gruber launched Marijuana Investigations for Neuroscientific Discovery (MIND), the first ever program of its kind designed to clarify the specific effects of medical cannabis use. MIND utilizes valid, robust research models and supports numerous projects designed to address the impact of medical cannabis on a number of important variables including cognition, brain structure and function, clinical state, quality of life, pain, sleep, and other health-related measures. As the director of MIND, Dr. Gruber has generated major contributions to the field as the first investigator to assess medical cannabis patients longitudinally, first to acquire neuroimaging data in medical cannabis patients, and as Principal Investigator of the first ever clinical trial of a whole plant-derived, high cannabidiol (CBD) product which she specifically formulated to treat anxiety; other novel clinical trials have been approved and are pending.

Dr. Sanjay Gupta is the multiple journalism award-winning chief medical correspondent for CNN and host of the CNN podcast Chasing Life. Gupta, a practicing neurosurgeon, plays an integral role in CNN’s reporting on health and medical news for all of CNN’s shows domestically and internationally, and regularly contributes to CNN.com.

Since 2001, Gupta has covered some of the most important health stories in the United States and around the world. On March 9, 2020, Gupta penned an op-ed announcing the network would refer to the novel coronavirus outbreak as a “pandemic,” ahead of the WHO and the CDC. Throughout 2020 into 2021, Gupta reaffirmed his role as a trusted guide to viewers worldwide on navigating between facts and fiction surrounding Covid-19 and the pandemic.

In addition to his work for CNN, Gupta is an associate professor of neurosurgery at Emory University Hospital and associate chief of neurosurgery at Grady Memorial Hospital in Atlanta. He serves as a diplomat of the American Board of Neurosurgery. And in 2019, Gupta was elected to the National Academy of Medicine, considered one of the highest honors in the medical field.

Gupta received his undergraduate degree from the University of Michigan and a Doctorate of Medicine degree from the University of Michigan Medical School.

Patrice A. Harris, MD, MA is the CEO and Co-Founder of eMed, a digital healthcare company. She is a board certified psychiatrist from Atlanta and has diverse experience as a private practicing physician, county public health director and patient advocate and expertise in policy, legislative and government affairs. Dr. Harris was the 174th President of the American Medical Association and the first African American woman elected to that position. Dr. Harris is a visiting professor of psychiatry at the Columbia University Vagelos College of Physicians and Surgeons and serves as Chief Health and Medical Editor of Everydayhealth.com.

Beyond the AMA she has held positions of leadership with the American Psychiatric Association, the Georgia Psychiatric Physicians Association, the Medical Association of Georgia, and The Big Cities Health Coalition, where she chaired this forum composed of leaders from America’s largest metropolitan health departments. She is a member of the Steering Committee of the Atlanta Regional Collaborative for Health Improvement (ARCHI) and the Board of the Georgia Aids Coalition. She also serves on the Board of Quartet Health.

Dr. Harris spent her formative years at West Virginia University, earning a BA in psychology, an MA in counseling psychology and, ultimately, a medical degree (MD). She completed her psychiatry residency and fellowships in child and adolescent psychiatry and forensic psychiatry at the Emory University School of Medicine

Dr. Harris is a highly sought after speaker at national and international conferences and has given invited lectures and presentations on COVID-19, children’s mental health, childhood trauma, integration of mental health into overall health services, health equity, health policy and the intersection of athletics and health. She has been a guest expert on multiple national radio and television networks including CNN, MSNBC, Fox and NPR. Dr. Harris has received numerous awards in recognition of her service and leadership.

Dr. Harris is fellow of the American Psychiatric Association and is adjunct assistant professor in the Emory Department of Psychiatry and Behavioral Sciences, and an adjunct clinical assistant professor in psychiatry and behavioral sciences at the Morehouse School of Medicine.

Jerry Harrison is the Co-Founder and Chairman of RedCrow™ Inc. a direct investment platform presenting professionally vetted investment opportunities in innovative healthcare startups to an accredited crowd of investors. Jerry is also a Co-Founder of Orphirex, Inc. a pioneer in the treatment of snakebites. Prior to RedCrow, Jerry was a Co-Founder of Garage Band, a record label which was a pioneer in using crowd-sourcing and the internet in general to identify promising artists to be signed and then released. Garageband became iLike and was sold to Myspace in 2009. Jerry has served on the Board of Directors for a number of other companies including MicroUnity, IODA and Carbon Gold.

Admired for his work as a musician Jerry performed as the keyboard player for The Modern Lovers. Their album recorded in 1972 but released in 1976 was an inspiration to the burgeoning punk rock movement. Also, In 1976, while a student at Harvard’s Graduate School of Design, Jerry met David Byrne, Chris Franz, and Tina Weymouth and left school to join the Talking Heads in January 1977, with whom he remained until the band’s break up in 1991. In 2002, The Talking Heads were inducted into the Rock and Roll Hall of Fame. Jerry has also released several solo albums as well as worked as an active music producer for some of rock and roll’s best-known bands including Live, The Fine Young Cannibals, Violent Femmes, Bodeans, Crash Test Dummies, Kenny Wayne Shepherd Band, No Doubt, Foo Fighters, Verb Pipe and the Von Bondies. A father of three children, he resides in Marin County, California with his wife of 31 years.

Mariel Hemingway is considered an expert in health—both mental and physical — and is a longtime advocate of personal power, life balance, authenticity, joy and finding peace of mind through a devoted practice of healthy living. She’s both a committed teacher and student in this holistic concentration. In 2014 Mariel co-executive produced the Emmy-nominated Running From Crazy, a rich and evocative documentary about the Hemingway family, collaboration with Oprah Winfrey. The film premiered at the Sundance Film Festival and documents her boundless advocacy for mental health awareness, the dignity and rights of people of all circumstance and ability, and her commitment to connecting those of like mind and heart in order to optimize their lives in the best and worst of times.

In May 2015, in alignment with National Mental Health Awareness month, Regan Arts Publishing released two new books including her memoir, “Out Came The Sun” and a young adult targeted diary form project about the journey from surviving to thriving, entitled “Invisible Girl.

In 2013, Mariel co-wrote the book, Running With Nature, wherein she and her life partner Bobby Williams share their insights about the import and impact of nutrition, meditation, mindfulness, movement, silence, the beauty of simple living, compassion for self and community, and staying a student of life at all ages. Mariel’s best-selling book, Finding My Balance, is an honest and inspiring story of her life’s journey through the lens of her personal yoga and meditation practices. Her second book, Mariel Hemingway’s Healthy Living from the Inside Out is a how-to guide to finding a greater sense of balance and meaning through self-empowering techniques and strategies. Her 2009 cookbook, Mariel’s Kitchen, offers creative gluten and sugar free recipes and was one of the first to shine the national spotlight on the benefits of this type of diet and lifestyle.

Mariel is a regular keynote speaker at conferences, conventions, and on academic panels where those of like mind and heart gather to educate, engage, entertain, and to enrich each other’s experiences. She is also an educator for groundtherapy.com and for Earthing.com  which promotes the natural anti inflammatory properties of grounding. She created a magazine dedicated to the practice of grounding called MH Earthing. 

Recent health, wellness, inspirational, advocacy and entertainment media profiles include those in USA Today, LA Times, The Chicago Tribune, The Times of London, The Today & Dr. Oz shows, Huffington Post/AOL video sites, Vanity Fair, the New York Times, Interview, People, and USA Today Best of Magazines. In 2014, Mariel was the focus of a one-hour interview about her books with Oprah Winfrey’s on OWN’s premiere show, Super Soul Sunday.

Mark Hoplamazian has served as Hyatt’s President and CEO since December 2006, following his appointment to Hyatt’s Board of Directors in November 2006. Prior to joining Hyatt, Mark spent time at the Pritzker Organization, L.L.C where he served as an advisor to various Pritzker family-owned companies, including Hyatt Hotels Corporation. He previously worked at The First Boston Corporation in New York.

Patty Horoho is the CEO of OptumServe, which provides technology, health services, data analytics and consulting for the U.S. Departments of Defense, Health and Human Services, Veterans Affairs, and others. After 33 years in the Army, Patty retired as Lieutenant General, the 43rd Army Surgeon General and Commander of the Army Medical Command, the first female and nurse to hold these posts. 

Design is Meija's not-so-secret weapon for creating a better food future. Meija brings a background in clinical psychology to design brands, products and experiences—from a communications platform to support former NFL players in healthy behavior change to award-winning wholesome kids snacks. She also serves on the board of Eat Real, a nonprofit tackling diet-related disease by supporting school districts to transform food programs.

Paul E. Jacobs, Ph.D., founded XCOM in 2018 to #keepinventing and to invest with the world’s most creative engineers and businesspeople.

As former chief executive officer and executive chairman of Qualcomm Incorporated, Dr. Jacobs spearheaded its efforts to develop and commercialize fundamental mobile technology breakthroughs that fueled the wireless internet and smartphone revolutions. During his tenure as CEO, Qualcomm’s revenues quadrupled and its market capitalization doubled. Dr. Jacobs is a prolific inventor with over 80 U.S. patents granted or pending in the field of wireless technology and devices.

He served as a director of Qualcomm Incorporated from June 2005 to March 2018, including as chairman of the board of directors from March 2009 to March 2018, and as executive chairman from March 2014 to March 2018. He served as chief executive officer from July 2005 to March 2014, and as group president of Qualcomm Wireless & Internet from July 2001 to July 2005. In addition, he served as an executive vice president of Qualcomm Incorporated from February 2000 to June 2005.

Dr. Jacobs is a director of Dropbox, Inc. and FIRST, and Chairman of Heal, a private technology enabled medical care company. He is an owner and vice chairman of the Sacramento Kings, who compete in the National Basketball Association (NBA). He attended the University of California, Berkeley, where he earned a B.S. in electrical engineering and computer science, M.S. in electrical engineering, and Ph.D. in electrical engineering and computer science. He founded Berkeley’s Jacobs Institute for Design Innovation and was the university’s 2017 Alumnus of the Year. Dr. Jacobs is a member of the National Academy of Engineering and a Fellow of the American Academy of Arts and Sciences.

Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well-known for his research into T cell therapies for the treatment of cancer.

Dean Kamen is an inventor, an entrepreneur, and a tireless advocate for science and technology. His roles as inventor and advocate are intertwined—his own passion for technology and its practical uses has driven his personal determination to spread the word about technology's virtues and by so doing to change the culture of the United States.

Dean Kamen is the founder and president of DEKA Research & Development Corporation. Examples of technologies developed by DEKA include the HomeChoice™ portable dialysis machine, the iBOT™ Mobility System, the Segway™ Human Transporter, a DARPA-funded robotic arm, a new and improved Stirling engine, and the Slingshot water purifier.

In addition to DEKA, one of Dean's proudest accomplishments is founding FIRST® (For Inspiration and Recognition of Science and Technology), an organization dedicated to motivating the next generation to understand, use and enjoy science and technology. Founded in 1989, this year FIRST® will serve more than 2,500,000 young people, ages 6 to 18, in more than 113 countries around the globe. Last year, high-school-aged participants were eligible to apply for more than $80 million in scholarships from over 200 leading colleges, universities, and corporations.

Kamen has received many awards for his efforts. Notably, Kamen was awarded the National Medal of Technology in 2000. Presented by President Clinton, this award was in recognition for inventions that have advanced medical care worldwide, and for innovative and imaginative leadership in awakening America to the excitement of science and technology. Kamen was elected a member of the National Academy of Engineering in 1997. He was awarded the Lemelson-MIT Prize in 2002, and was inducted into the National Inventors Hall of Fame in May 2005. He is a Fellow of the American Institute for Medical & Biological Engineering, as well as many other national and international engineering organizations.

Ruth J. Katz is a Vice President and the Executive Director of the Health, Medicine and Society (HMS) Program at the Aspen Institute, an educational and policy studies organization based in Washington, DC. Established in 2005, HMS brings together influential groups of thought leaders, decisionmakers, and the informed public to consider health challenges facing the US in the 21st century and to identify practical solutions for addressing them.

Ms. Katz joined the Aspen Institute after serving from 2009 to 2013 as Chief Public Health Counsel (Democratic Staff) with the Committee on Energy and Commerce in the U.S. House of Representatives. Prior to her work with the Committee, Ms. Katz was the Walter G. Ross Professor of Health Policy of the Milken Institute School of Public Health at the George Washington University. She served as the dean of the School from 2003 to 2008. Ms. Katz was, from 1997 to 2003, Associate Dean for Administration at the Yale University School of Medicine, where she also held appointments in the departments of Internal Medicine (General Medicine) and Epidemiology and Public Health as an Assistant Professor.

Ms. Katz, a magna cum laude graduate of the University of Pennsylvania, holds a law degree from Emory University and a Masters of Public Health from Harvard. She served for over a decade, from 1982 to 1995, as Counsel to the Subcommittee on Health and the Environment of the Committee on Energy and Commerce in the U.S. House of Representatives. In addition, Ms. Katz was, from 1995 to 1996, Director of Public Health Programs at the Henry J. Kaiser Family Foundation; and, in 1997, Counsel to the Advisory Committee on Tobacco Policy and Public Health, chaired by Drs. C. Everett Koop and David Kessler. She was engaged in the private practice of law from 1977 to 1979.

In addition to her duties with the Aspen Institute, Ms. Katz currently is a member of the board of Directors of the CDC Foundation and EngenderHealth, and has been a member of the board of trustees of Emory University and the board of directors of NARAL Pro-Choice America. She has also completed terms as a member of the Advisory Committee to the NIH Office of Research on Women’s Health; the Advisory Committee to the Director of CDC; CDC’s National Vaccine Advisory Committee; the National Advisory Committee for the Robert Wood Johnson Health & Society Scholars Program and the Finalist Selection Committee of the Harry S. Truman Scholarship Foundation.

Mia Kyricos joined Hyatt as the company’s first Senior Vice President & Global Head of Wellbeing in 2018. In this role, Mia oversees Hyatt’s holistic wellbeing strategy for colleagues, guests and customers around the world. With over 25 years of experience, Mia has helped to develop, operate and market wellness-related brands, products and services across 100+ countries. Recently named a “Leading Woman in Wellness 2019” at the 2019 Global Wellness Summit.

Clifton Leaf is a Global Fellow at the Ellison Institute for Transformative Medicine and an Adjunct Professor of Journalism at Columbia University’s Graduate School of Journalism. Previously (until June 2021) he was the 19th Editor-in-Chief of FORTUNE, where he directed the editorial content and strategy across all of FORTUNE’s platforms, shepherding this venerable publication through its 90th anniversary and beyond. During his nearly four-and-a-half-year tenure as Editor-in-Chief, FORTUNE was honored with more than 70 top journalism prizes, earned high acclaim for its print magazine redesign, substantially expanded its digital offerings and audience, and built formidable newsletter, premium subscription, podcast, virtual events, and professional networking businesses. Previously, he served as Deputy Editor of FORTUNE for three years, overseeing the print magazine, and before that was a guest editor for the New York Times op-ed page and Sunday Review. Earlier in his magazine career, he was Executive Editor both at the Wall Street Journal’s SmartMoney magazine and at FORTUNE. He is also the author of the critically acclaimed book, The Truth in Small Doses: Why We’re Losing the War on Cancer—and How to Win It, which was named by Newsweek as one of “The Best Books About Cancer,” and which earned Cliff a Lifetime Achievement Award for cancer reporting from the European School of Oncology. A winner of the Gerald Loeb Award for Distinguished Business and Financial Journalism, the NIHCM’s Health Care Journalism Award, and a two-time finalist for the National Magazine Award, Cliff has received numerous leadership honors for his efforts in the cancer fight, including the Ribbon of Hope from the National Coalition for Cancer Survivorship. A member of the Board of Fellows at the Stanford University School of Medicine and a keynote speaker at more than three dozen scientific conferences around the world, Cliff has presented testimony to the President’s Cancer Panel three times and delivered “Grand Rounds” at the National Cancer Institute. He is the first and only journalist to have received that honor.

Eric Lefkofsky is the founder and CEO at Tempus, a leading provider of technology enabled precision medicine solutions. He is a founding partner of Lightbank, a venture fund investing in disruptive technology businesses. He is also the co-founder and Chairman of Groupon (NASDAQ: GRPN), a global e-commerce marketplace, and co-founder of Mediaocean, a leading provider of integrated media procurement technology; Echo Global Logistics (NASDAQ: ECHO), a technology-enabled transportation and logistics outsourcing firm; InnerWorkings (NASDAQ: INWK), a global provider of managed print and promotional solutions and a founding investor of Uptake Technologies, a leading predictive analytics platform for the world’s largest industries.

He co-chairs the Lefkofsky Family Foundation with his wife Liz to advance high-impact initiatives that enhance lives in the communities served. Lefkofsky serves as a Trustee of Lurie Children’s Hospital of Chicago, The Art Institute of Chicago, The Museum of Science and Industry, and World Business Chicago. He is also Chairman of the Board of Trustees of Chicago’s Steppenwolf Theatre Company. Lefkofsky is an adjunct professor at the University of Chicago and author of Accelerated Disruption: Understanding the True Speed of Innovation. He graduated from the University of Michigan and received his Juris Doctor at University of Michigan Law School.

Alan Lotvin, M.D., is executive vice president and chief transformation officer for CVS Health. In this role, Lotvin has oversight of the portfolio of business transformation initiatives across the enterprise with a focus on identifying opportunities for growth and innovation to create new health care experiences that are easier to use, less expensive and place consumers at the center of their care.

Lotvin has extensive experience in the pharmaceutical benefit management and specialty pharmacy industries. Prior to his current role, he served as executive vice president of CVS Specialty, the specialty pharmacy of CVS Health. Before joining the company, Lotvin was president and chief executive officer of ICORE Healthcare, a Magellan Health Services company. Previously, Lotvin held multiple roles at Medco Health Solutions, including president of Medco Specialty Pharmacy Services and senior vice president of Manufacturer Contracting.

Lotvin began his career as a practicing cardiologist in New Jersey. He holds a master's degree in Medical Informatics from Columbia University and a medical degree from the State University of New York Health Sciences Center in Brooklyn. Lotvin also holds US Patent #6269819 Method and Apparatus for Circulatory Valve Repair.

Poonacha Machaiah is the CEO of The Chopra Foundation, dedicated to improving health, social and planetary wellbeing. Co-founder and CEO of Seva.Love the metaverse platform for wellbeing and ChopraX, a venture studio backing transformative entrepreneurs who are reimagining the future of health and wellbeing, along with world-renowned mind-body medicine pioneer and New York Times best-selling author Deepak Chopra, MD.

He has co-founded initiatives such as NeverAlone® to address mental wellbeing and suicide prevention. Co-founded CIRCA®, an anxiety management platform along with Srini Pillay, MD -- Harvard-Trained psychiatrist and brain researcher.

He is on the board of transformative companies such as The Healing Company, Beacon Media, Limitless Minds and Reulay. He has also held senior management positions at Nortel, Iridium, Motorola and Sasken. He holds an MBA from the College of William and Mary, and a Bachelor of Science in Computer Science and Engineering.

Tod Machover has been called “America’s most wired composer” by The Los Angeles Times, and “a musical visionary” by The New York Times. He is also celebrated internationally for inventing new technologies that expand music’s potential. Mr. Machover studied with Elliott Carter and Roger Sessions at the Juilliard School, served as composer-in-residence at the Lucerne Festival, and was the first director of musical research at Pierre Boulez's IRCAM in Paris. He is a founding member and Academic Head of the MIT Media Lab, where he is also the Muriel R. Cooper Professor of Music and Media and director of the Opera of the Future group. He is currently a visiting professor at the Royal Academy of Music (London) and the Curtis Institute of Music (Philadelphia).

Machover’s work has been awarded prizes and honors from the American Academy of Arts and Letters, the Fromm and Koussevitzky music foundations, the National Endowment for the Arts, the German and French ministries of culture, and the World Technology Network. He was the first recipient of the Arts Advocacy Award from the Kennedy Center’s National Committee for the Performing Arts, and was honored as Musical America's 2016 Composer of the Year. His “robotic” opera Death and the Powers was a finalist for the 2012 Pulitzer Prize in Music. His latest opera, Schoenberg in Hollywood, premiered to great critical success at Boston Lyric Opera in November 2018, and travels to Vienna in April 2020.

Mr. Machover’s latest addition to his collaborative “City Symphony” series, Philadelphia Voices, was premiered by the Philadelphia Orchestra under Yannick Nézet-Séguin in April 2018, followed by a New York debut at Carnegie Hall. His Symphony in D for the Detroit Symphony Orchestra was the subject of an Emmy award-winning documentary in 2017, currently being broadcast throughout the U.S. on American Public Television. He is now working on the next group of City Symphonies - that combine “musical” and “found” materials, and invite whole communities to collaborate - in Boston, Dubai, Chennai (India) in collaboration with celebrated film composer A.R. Rahman, and in both Koreas for a Symphony for the Koreas, in collaboration with the Lindenbaum Orchestra/Festival.

Mr. Machover’s compositions have been commissioned and performed by many of the world’s most prominent ensembles and soloists such as the Ensemble InterContemporain, the London Sinfonietta, Ensemble Modern, Houston Grand Opera, the San Francisco Symphony, the Los Angeles Philharmonic, and the BBC Symphony; the Tokyo, Kronos, and Ying string quartets; and renowned artists such as Yo-Yo Ma and Joshua Bell, among many others.

Mr. Machover’s innovations in music technology have led to a new generation of musical instruments - called Hyperinstruments - that expand expression for both virtuosi and amateurs, to tools for musical creativity and participation such as Hyperscore software and video games like Guitar Hero, to new tools and therapies for promoting health and wellbeing as well as for diagnosing and curing diseases such as Autism and Alzheimer’s, the latter using state-of-the-art MIT research into the positive effects of 40-hertz Gamma frequencies in synchronizing and revitalizing the mind.

James L. Madara, MD, is CEO of the American Medical Association. His career began with 20+ years at Harvard where he received clinical and research training, served as a tenured professor of pathology and was director of the NIH-sponsored Harvard Digestive Disease Center. After five years as chair of pathology (Emory), Madara served as the Thompson Distinguished Service Professor and dean of the University of Chicago Pritzker School of Medicine, and as CEO of the University of Chicago Hospitals. Along with his current position, Madara is chairman of Health2047 Inc. An independent C-corporation, Health2047 is a San Francisco-based design firm whose mission is to help advance the AMA’s goal of improving the health of the nation through innovative solutions.

Chris Mann is a recording star and actor who’s albums have topped the Billboard and iTunes charts. Mann lit up a global audience with his 2012 post Super Bowl XLVI performance on NBC’s The Voice which was watched by a record-breaking 37.6 million viewers. Mann was later cast by Andrew Lloyd Webber as The Phantom in The Phantom of the Opera's 25th Anniversary Tour. Mann donned the iconic mask for over 700 performances with critics hailing him as “the best Phantom since Michael Crawford.” He has spoken at the TedX Talks with Dr. Rudy Tanzi about his family’s connection to Alzheimer’s Disease and their song, Remember Me, which was written to raise money for Cure Alzheimer’s Fund research.

Fred Maxik is one of the world’s foremost experts in Solid State Lighting. He is the Founder and Chief Technology Officer of Lighting Science, the premier developer and manufacturer of ground-breaking circadian LED bulbs and lighting systems. He has over 25 years of experience designing environmentally friendly technologies. He is the principal inventor on more than 200 patents in the United States, and more than 400 worldwide, and has published several papers on light and its interaction with biological systems. His current project interests include biological lighting, net positive sustainable infrastructure and expanding sensing capabilities and analytics.

Mr. Maxik speaks regularly on the future of light and sustainability at global strategy and technology conferences, universities, as well as the United Nations. He is a member of the Board of Trustees of Bard College, and has been awarded the Champion for Change Award (White House, U.S.), A Congressional Medal of Merit (Congress, U.S.), the NASA Group Achievement Award, Friends of the Phelophepa Award, given by Desmond Tutu and the John and Samuel Bard Award in Science and Medicine. His extensive knowledge on the biological effects of light earned a research grant through the Australian Government’s Cooperative Research Centres Program for Alertness, Safety and Productivity. His first book, The Meaning of Light, was published in 2011. Associations: IESNA, MRS, ASP.

Mark McClellan, MD, PhD, is Director and Robert J. Margolis, M.D., Professor of Business, Medicine and Health Policy at the Margolis Center for Health Policy at Duke University. He is a physician-economist who focuses on quality and value in health care, including payment reform, real-world evidence and more effective drug and device innovation. He is former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. He is an independent director on the boards of Johnson & Johnson, Cigna, Alignment Health Care and Seer, and is co-chair of the Accountable Care Learning Collaborative and the Guiding Committee for the Health Care Payment Learning and Action Network.

Todd Monrad is the Vice President of the Health, Corporate, and Performance division with Technogym North America. Todd was recruited by Technogym 12 years ago, with a background in Athletic Training and hospital administration, to strategically grow Technogym’s presence in this competitive market.

Dr. Moore leads Microsoft’s Health efforts globally and is responsible for product strategy, product development, and research including AI and machine learning technology for healthcare and life sciences. He is also Microsoft’s senior executive leading dedicated research and development collaborations with Microsoft’s strategic alliance partners in this domain with the goal of enabling a more open, interoperable, and AI-infused foundation for healthcare delivery that aspires to enable access to healthcare for all globally.

R. Lawrence Moss, MD, FACS, FAAP is president and CEO of The Nemours Foundation. Nemours is an integrated Children’s Health System with two free-standing hospitals in Delaware and Florida serving children from across the U.S. and internationally. Nemours is one of the largest integrated children’s health systems in the country, with two freestanding state-of-the-art children’s hospitals — Nemours Alfred I. duPont Hospital for Children in Wilmington, Del., Nemours Children’s Hospital in Orlando.

With more than 1.7 million patient encounters annually, Nemours provides medical care in five states with more than 80 primary- urgent- and specialty care practices serving children in Delaware, Florida, New Jersey, Pennsylvania and Georgia. More than 40 hospitalists serve 18 affiliated hospitals, helping keep the best possible care for children local, and Nemours CareConnect provides parents peace of mind 24/7 with telehealth services delivered by board certified pediatricians.

Dr. Moss is a renowned pediatric surgeon, biomedical researcher, educator, and health system executive. He is internationally recognized for leadership in healthcare quality and safety, including service as a founding director for developing quality standards for pediatric surgery nationally. He is known for tremendous achievements in academic health centers, national hospital associations, and government organizations accountable to the public. He is also an accomplished research scientist with a track record of federal funding, high-impact peer reviewed publications, and creating and leading successful research centers of excellence.

He joined Nemours on Oct. 1, 2018, after serving seven years as Surgeon-in-Chief at Nationwide Children’s Hospital in Columbus, Ohio, and the E. Thomas Boles Jr., Professor of Surgery at The Ohio State University College of Medicine. A pediatric surgeon for more than 26 years, Dr. Moss was an integral part of the Nationwide team that transformed its surgery program into an academic powerhouse influencing children’s surgery worldwide and consistently ranked as one of the elite programs in the world.

Under his leadership, the program developed the first FDA approved studies in Tissue Engineering for congenital heart disease, internationally renowned centers in colorectal and craniofacial care, and more than a dozen federally funded surgical research programs. He is internationally known for the application of clinical trials and evidence- based techniques in children's surgery. Dr. Moss, while growing and supporting 12 departments, also initiated, designed, and executed the first ever multi-center clinical trial in children’s surgery, funded by the National Institutes of Health (NIH), and published in The New England Journal of Medicine.

He previously served as the Robert Pritzker Professor and Chief of Children’s Surgery at Yale University and as a faculty member at Stanford University School of Medicine. Dr. Moss has a longstanding interest in clinical trials, assessment of surgical outcomes, and quality improvement. He has authored over 150 research publications, edited textbooks, and presented his work nationally and internationally. He has successfully competed for and received more than 15 years of continuous research funding from multiple sources including the NIH, FDA, and private foundations, including the Robert Woods Johnson Foundation. He is also known for his interest in necrotizing enterocolitis (NEC) and other life threatening problems in infants and has led a multi-center consortium investigating biologic predictors of outcomes and novel therapies for NEC.

Dr. Moss attended medical school at the University of California, San Diego, and completed General Surgery Residency at Virginia Mason Medical Center in Seattle. He then moved to Chicago and completed Extracorporeal Membrane Oxygenation/Critical Care and Pediatric Surgery fellowships at Northwestern University. Dr. Moss holds numerous leadership positions in surgical societies nationally, and is a founding member of the American College of Surgeons Pediatric National Surgical Quality Improvement Program. He has served as the Director of Quality Improvement programs in both pediatric and adult academic medical centers and has held leadership and advisory roles in health quality for the American Academy of Pediatrics, FDA, and the Agency for Healthcare Research and Quality.

He is past Chairperson of the Surgical Section of the American Academy Pediatrics and is currently the President of the Children’s Hospital Association Surgeons-in-Chief Forum. Dr. Moss is serving in a founding leadership role in the American College of Surgeons Children's Surgery Verification program. This group is developing verification standards for centers performing children’s surgery in the United States. He was selected to serve on the National Quality Forum Surgical Standing Committee. He also serves in leadership positions in Quality Improvement in the Children’s Hospital Association, American Pediatric Surgical Association, and the American Academy of Pediatrics. Dr. Moss has been listed in Best Doctors in the United States continually since 2004.

Dr. Moss also serves the interests of children through volunteer service to Handshake America, and serves on the Boards of Children’s Chance and Morgan Leary Vaughan Fund, Inc.

Brian Moynihan leads a team of more than 200,000 employees dedicated to making financial lives better for people, companies of every size, and institutional investors across the United States and around the world.

In 2019, Bank of America was the only financial services company on Fortune magazine’s list of The Best Big Companies to Work For. Euromoney recognized Bank of America in 2018 as the World’s Best Bank and the World’s Best Bank for Diversity and Inclusion, as part of their annual Global Awards for Excellence. Bank of America is recognized as a top employer by Working Mother magazine and Military Times and by JUST Capital as the #1 most JUST company out of “Banks” industry. The company is also listed on Fortune magazine’s list of the Best Workplaces for Diversity and the Best Workplaces for Parents. It was also named one of the Best Places to Work for Disability Inclusion by the U.S. Business Leadership Network and the American Association of People with Disabilities. Bank of America was also named the 2019 Catalyst Award winner, honored for supporting the continued development, empowerment and advancement of women in the company and around the world.

Moynihan participates in several organizations that focus on economic and market trends, including as chairman of the World Economic Forum International Business Council, the Financial Services Forum, the Bank Policy Institute (chair), the Business Roundtable, the Clearing House, the American Heart Association CEO Roundtable (co-chair) and the Business Council. He is a member of the Federal Advisory Council of the Federal Reserve Board.

Moynihan leads the company’s Global Diversity and Inclusion Council and is a member of the museum council for the Smithsonian’s National Museum of African American History and Culture. Moynihan is also a member of the Brown University Corporation's Board of Fellows, the Catalyst Board of Directors, the Council on Competitiveness Board of Directors, the Congressional Medal of Honor Foundation Board and the Appeal of Conscience Board of Trustees.

Moynihan works with public officials, businesses and civic leaders at the local level through his participation on the Charlotte Executive Leadership Council (chair), the Massachusetts Competitive Partnership and the Partnership for Rhode Island.

Dariush Mozaffarian is a cardiologist, Jean Mayer Professor at the Friedman School of Nutrition Science and Policy at Tufts University, Professor of Medicine at Tufts School of Medicine, and an attending physician at Tufts Medical Center. His work aims to create the science and translation for a food system that is nutritious, equitable, and sustainable. Dr. Mozaffarian has authored more than 500 scientific publications on dietary priorities for obesity, diabetes, and cardiovascular diseases, and on evidence-based policy approaches and innovations to reduce diet-related diseases and improve health equity in the US and globally. Areas of focus include defining healthy diets, nutritional biomarkers, Food is Medicine interventions in healthcare, business innovation and entrepreneurship, and food policy. He is one of the top cited researchers in medicine globally, he has served in numerous advisory roles, and his work has been featured in an array of media outlets. Thomson Reuters has named him as one of the World's Most Influential Scientific Minds In 2023, Dr. Mozaffarian was nominated by President Biden to serve on the President’s Council on Sports, Fitness, and Nutrition (PCSFN), a federal advisory committee that aims to promote healthy eating and physical activity for all Americans.

Dr. Mozaffarian received his B.S. in biological sciences from Stanford University, M.D. from Columbia University, and Doctorate in Public Health from Harvard University; and additional clinical training in internal medicine at Stanford University and in cardiology at the University of Washington. He is married, has three children, and actively trains as a Fourth Degree Black Belt in Taekwondo.

Dr. Rao Mulpuri is the CEO of View, a technology company that creates smart and connected buildings to improve people’s physical and mental health, while simultaneously reducing energy consumption. Since its inception ten years ago, View has developed groundbreaking technology and products that are now installed in and designed into more than 90M square feet of buildings—and counting.

Prior to View, Dr. Mulpuri held several executive positions at Novellus Systems, most recently President of Novellus Systems Japan. He holds a BE in Mechanical Engineering from Manipal Institute of Technology, India, as well as an MS in Manufacturing Engineering and a Ph.D. in Materials Engineering from Boston University. He also completed the Advanced Management Program at Harvard Business School. Dr. Mulpuri is a member of the Young Presidents Organization and the Urban Land Institute and serves on the Executive Board of the Silicon Valley Leadership Group, the Advisory Board of the College of Engineering at Boston University, and the Advisory Board of Stanford University CARE.

Alan Murray is CEO of Fortune Media, where he oversees all of the company’s operations. He writes a closely-read newsletter, the Fortune CEO Daily, and cohosts a weekly podcast, Leadership Next. He is the author of five books, including most recently Tomorrow’s Capitalist: My Search for the Soul of Business. Prior to joining Fortune in 2015, Murray led the Pew Research Center. Before that, he was at the Wall Street Journal for many years, serving as Deputy Managing Editor, Executive Editor Online, Washington Bureau Chief, and author of the Political Capital and Business columns. He also served for a time as Washington bureau chief of CNBC, and co-host of the network’s Capitol Report.

Laura Newinski is Deputy Chair and COO of KPMG LLP. In this role, Laura chairs the U.S. Management Committee and is responsible for the development of the U.S. firm’s strategy and the execution of its priorities. She is a member of the U.S. firm’s Board of Directors. Laura also serves as Deputy Chair for the Americas region and is a member of both the Americas Board of Directors and Management Committee. Laura is a member of both KPMG’s Global Board of Directors and Executive Committee.

During Laura’s 35-year career, she has had extensive experience serving multinational Fortune 500 companies and leading various areas of the firm. Laura is recognized for her insights on business strategy, operations, talent, culture and tax, as well as her unwavering commitment to quality and integrity and focus on building strong, diverse and inclusive teams.

Laura has been a member of the U.S. Management Committee since 2015. Prior to her current role, she served as Vice Chair of Operations and was responsible for technology, including digital transformation, data strategy, technology operations and security, as well as financial matters encompassing forecasting, planning, and monitoring the firm’s financial performance. In addition, she also oversaw operations including pension investments, real estate, corporate development, firmwide investments portfolio and internal audit.

As a result of Laura’s leadership and focus on operational excellence, KPMG has made substantial progress toward digitalization, resulting in significant improvements in productivity, cost-efficiency, and client service delivery. She co-led the planning and development of KPMG Lakehouse, the firm’s state-of-the-art training facility and cultural home, and a host location for LNIF since it was opened.

Her previous leadership roles at KPMG included serving as the National Managing Partner of Tax for KPMG and her client service roles have focused on both publicly held and large private companies in the financial services and food and beverage sectors.

Laura serves on the boards of Junior Achievement USA and the Greater Twin Cities Youth Symphony. She is a member of the University of Minnesota Carlson School of Management’s Board of Advisors. She previously served as a member of the University of Iowa Tippie Advisory Board, as a board member for Catholic Charities and Chair of the Board of Vail Place, a nonprofit organization that provides community-based mental health recovery services.

Dr. David Nill is the VP and Chief Medical at Cerner responsible for the health and wellbeing of the global Cerner population. He is responsible for the clinical strategy that aligns to benefits and on-site services offered to positively affect the health of Cerner associates and their families.

David Pacitti is President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers. Based at the U.S. headquarters of Siemens Healthineers in Malvern, Pennsylvania, Pacitti is responsible for leading the marketing, sales, service, and support functions in North America and Latin America, across the entire Healthineers portfolio, including medical imaging, laboratory diagnostics, therapy solutions, and services.

Prior to joining Siemens Healthineers in 2015 in his current role, Pacitti was Division Vice President of U.S. Commercial Operations, Sales, and Marketing at Abbott Vascular for two years, overseeing the company’s business in North America. As a member of the Senior Executive Staff, he worked with the CEO, CFO, and Research & Development team on business development initiatives and played pivotal roles in key launches, including Abbott Vascular’s first drug-eluting stent franchise and structural heart franchise. Prior to this position, Pacitti was Vice President of Abbott Vascular’s Commercial Operations from 2009 to 2013, and Vice President of Global Marketing from 2006 to 2009. He joined Abbott Vascular with its acquisition of Guidant Corp, where he served in positions of increasing responsibility from 1995 to 2006. Early in Pacitti’s career, he was a sales representative in Siemens’ Molecular Imaging business.

Pacitti is a member of the boards of Apollo Endo-Surgery, the Advanced Medical Technology Association (AdvaMed), the University City Science Center in Philadelphia, PA, the National Electrical Manufacturers Association (NEMA), and the Siemens Foundation. He is also a member of the CEO Council for Growth at the Chamber of Commerce for Greater Philadelphia as well as the Children’s Hospital of Philadelphia Corporate Council.

A Philadelphia area native, Pacitti holds a Bachelor of Arts degree with a minor in Economics from Villanova University, where his football prowess earned him induction into the Villanova Varsity Club Hall of Fame in 2006. Following college, he signed a free agent contract in 1990 with the Miami Dolphins as an offensive lineman. The father of three sons and two daughters in addition to being a grandfather, Pacitti resides with his wife and children in West Chester, Pennsylvania.

Jonathan B. Perlin, MD, PhD became the seventh President and CEO of The Joint Commission Enterprise on March 1, 2022. The Joint Commission Enterprise includes The Joint Commission, Joint Commission Resources (JCR), Joint Commission International (JCI) and the National Quality Forum (NQF).

Previously, as President, Clinical Operations and Chief Medical Officer, HCA Healthcare, Dr. Perlin led clinicians, data scientists and researchers in developing a learning health system model for improving care at the system’s 189 hospitals and 2,200 other locations. His team’s work achieved national recognition for preventing elective pre-term deliveries, reducing maternal mortality, using artificial intelligence to improve sepsis survival, and developing public-private-academic partnerships for improving infection prevention and treating COVID-19. Dr. Perlin’s CHARGE consortium partnered HCA, the Agency for Healthcare Research and Quality (AHRQ) and academia to create a reusable platform for accelerated research using real-world evidence from the care of over 400,000 COVID inpatients.

Before HCA, Dr. Perlin was Under Secretary for Health in the U.S. Department of Veterans Affairs (VA), where he led the Veterans Health Administration (VHA) to national prominence for full implementation of a national electronic health record and benchmark clinical performance. He has served on numerous Federal Commissions including as a Congressional Budget Office Health Advisor, a member of MedPAC (Medicare Payment Advisory Commission), and as chair of the VA Special Medical Advisory Group. An elected member of the National Academy of Medicine (NAM), he has co-chaired NAM action collaboratives on digital health, combatting opioids and climate change.

Dr. Perlin’s board service includes Columbia University’s Health Policy and Management program, Vanderbilt University’s School of Engineering, and he served as a Trustee of Meharry Medical College for 15 years. Perennially recognized as one of the most influential leaders in healthcare, Dr. Perlin maintains faculty appointments at Vanderbilt University as a Clinical Professor of Medicine and at Virginia Commonwealth University as an Adjunct Professor of Health Administration.

Ms. Peterson joined Clayton Dubilier & Rice (CD&R) as an operating partner in 2019, where she spans consumer and healthcare investing and spearheads the firm’s efforts to creating technology and digital capacity to support its investments and portfolio companies. Prior to CD&R, she was group worldwide chairman of Johnson & Johnson, where her portfolio included medical devices, consumer, global operating infrastructure, technology, supply chain and key strategic initiatives. Previously, Ms. Peterson served as Chairman & CEO of Bayer CropScience AG, CEO of Bayer Medical Care, and president of Bayer HealthCare AG’s Diabetes Care Division. She started her career at McKinsey and has held executive positions at Medco Health Solutions (formerly known as Merck-Medco), Nabisco, and Whirlpool. Ms. Peterson is the lead independent director of the Microsoft board of directors, chairman of the board of the American Academy in Berlin, serves as international advisory board member to global strategic advisory firm Hakluyt & Company, and is on the board of the Institute for Advanced Study, the world- renowned center for science and humanities research in Princeton, NJ. Ms. Peterson is also Executive Chairman of Volastra, an early-stage life science company.

Previously, Peterson was chairman of EcoHealth Alliance, the world’s foremost global institution at the forefront of pandemic detection and mitigation. She was also a member of the board of directors of The Dun & Bradstreet Corp. where she chaired the Innovation & Technology Committee. She has appeared on FORTUNE Magazine’s list of Most Powerful Women numerous times and was featured on the Magazine’s inaugural list of Leaders Who Are Changing Healthcare. Ms. Peterson attended Princeton University (M.P.A., Applied Economics), and Cornell University (B.A., Government).

Louie Psihoyos is an Academy Award-winning filmmaker and Executive Director of the Oceanic Preservation Society (OPS). He is recognized as one of the top still photographers in the world, having created iconic images for National Geographic and hundreds of covers and stories for other magazines around the world. His ability to bring humanity and wit to complicated science stories carries over to his filmmaking. Psihoyos’ first film, The Cove, won the Oscar for Best Documentary Film of 2009 and over 75 other awards around the world. His second film, Racing Extinction, aired in 220 countries and territories, and the impact campaign which involved projections of endangered species on the UN, The Empire State Building and the Vatican, gathered billions of views and helped create laws that prevent the trafficking of endangered species through U.S. ports.  The most recent film he directed, Game Changers, is executive produced by James Cameron, Arnold Schwarzenegger and Jackie Chan, is about plant-based super athletes and dispels the myth that animal based foods are optimal for health and nutrition.

Toby Redshaw is responsible for Verizon’s Enterprise Innovation and 5G Solutions Business. He previously ran the 5G Ecosystems, Innovation and Product Development, AR/VR and Location Services/Geo Intelligence Business.
Prior to joining Verizon, Toby was most recently CEO of Kevington Advisors, a leading edge consultancy offering services in enterprise technology strategy, coaching start-ups and various government/military engagements.

Avik Roy is the President of the Foundation for Research on Equal Opportunity (FREOPP.org), a non-partisan, non-profit think tank that conducts original research on expanding opportunity to those who least have it. Roy’s work has been praised widely on both the right and the left. National Review has called him one of the nation’s “sharpest policy minds,” while the New York Times’ Paul Krugman described him as man of “personal and moral courage.”

Roy also serves as the Policy Editor at Forbes, where he writes on politics and policy, and manages The Apothecary, the influential Forbes blog on health care policy and entitlement reform. Hugh Hewitt has called Roy “the most influential conservative analyst on health care.” NBC’s Chuck Todd, on Meet the Press, said Roy was one “of the most thoughtful guys [who has] been debating” health care reform. MSNBC’s Chris Hayes calls The Apothecary “one of the best takes from conservatives on that set of issues.” Ezra Klein, editor-in-chief of Vox.com, called The Apothecary one of the few “blogs I disagree with [that] I check daily.”

Roy is the author of Affordable Health Care for Every Generation: A Patient-Centered Plan for Universal Coverage and Permanent Fiscal Solvency, published by FREOPP in 2019; How Medicaid Fails the Poor, published by Encounter Books in 2013; and other books. He serves on the advisory board of the National Institute for Health Care Management, is a Senior Advisor to the Bipartisan Policy Center, and co-chaired the Fixing Veterans Health Care Policy?Taskforce.

Roy’s writing has also appeared in The Wall?Street Journal, The New York Times, The Washington Post, USA Today, The AtlanticNational Review, The Weekly Standard, and National Affairs, among other publications.

He is a frequent guest on television news programs, including appearances on Fox News, Fox Business, CNN, NBC, MSNBC, CNBC, Bloomberg, CBS, PBS, and HBO.

From 2011 to 2016, Roy served as a Senior Fellow at the Manhattan Institute for Policy Research. Previously, he served as an analyst and portfolio manager at Bain Capital, J.P. Morgan, and other firms.

He was born and raised near Detroit, Michigan, and graduated from high school in San Antonio, Texas. USA Today named him to its All-USA High School Academic First Team, honoring the top 20 high school seniors in the country. Roy was educated at the Massachusetts Institute of Technology, where he studied molecular biology, and the Yale University School of Medicine.

Nicole Sawyer is an award-winning multi-platform journalist, masterful businesswoman and innovative thinker.  Her exceptional story telling has aired across several major television networks as well as digital and print publications.

Nicole has extensive background in business and a knack for turning ideas into tangible results.  She has created original digital series for ABC News and produced for award winning shows 20/20, Nightline, World News, Good Morning America, CNBC’s “Squawk Box” and was a founding member of The FOX Business Network, News Corp’s financial news network, where she launched and developed several of the network’s prime time shows.

For over a decade Nicole has written stories focused on business, travel and wellness. She’s arranged interviews with some of the most influential people in the world, including Pope Francis, HRH Princess Lamia Al Saud of Saudi Arabia, Jeff Bezos, Deepak Chopra and fashion icons Michael Kors and Diane Von Furstenberg.

Nicole is a two-time Edward R. Murrow award recipient.

Sawyer is currently the Programming Director for Bloomberg Live and Host of the TV show Inspired with Nicole Sawyer. Watch new episodes on United Airlines, in airports and luxury hotel rooms across the U.S. via ReachTV. She is also a regular contributor to Thrive Global, the Huffington Post and Entreprenuer.com.

Brooke Shields began her modeling career at 11 months old in an Ivory Soap commercial. As a 14 year old model, Brooke was the youngest fashion model ever to appear on the cover of Vogue magazine. That same year, she appeared in the now-famous, controversial Calvin Klein jeans ad. By 16, she had become one of the most recognizable faces in the world.

At age nine, she appeared in her first film, Alice Sweet Alice, and rapidly gained fame after staring in Louis Malle's Pretty Baby and the coming-of-age tales Blue Lagoon and Endless Love. As a model, Brooke has graced the covers of hundreds of magazines, most notably as Time Magazine's "Face of the Eighties." Today, Shields continues her prolific career on screen and stage, as a best-selling author and an advocate for women and the arts.

In addition to her film achievements, Shields has maintained a successful and acclaimed television career. Her work on “Suddenly Susan” garnered her a Golden Globe nomination and five People's Choice Awards. She currently can be seen on “Law & Order: SVU” in a major recurring role and is featured in the indie drama Daisy Winters, released fall of 2017. Brooke also had a Sirius XM show, "Brooke Shields Now," which covered topics such as parenting, relationships and style.
In 2006, Brooke wrote her best-selling memoir, Down Came the Rain, detailing her struggles with post-partum depression, its impact on her family and friends, and her use of therapy & medication. The book created a watershed moment in public awareness of the disease. In 2014, Shields released her memoir There Was a Little Girl, a candid look at her relationship with her mother, who was both her manager and an alcoholic. The memoir is a raw and unguarded look at the damage alcohol causes in intimate relationships.

Incorporating decades of experience working in the fashion world, Brooke created an apparel and accessories line exclusively for QVC called Brooke Shields Timeless. This is her first apparel collection. The line will feature a selection of separates, including classic button-ups, flowy blouses, tailored bottoms, flirty skirts, colorful scarves and contemporary fashion jewelry. Brooke’s collection officially launched in March 2018 on QVC.

While attending Princeton University, Brooke pursued her love of theatre as a member of the Princeton Triangle Club. Shortly after graduating with an honors degree in French literature, she made her Broadway debut as Rizzo in the hit musical Grease, for which she earned the Theatre World Award in 1994 for "Outstanding Debut on Broadway." Shields also starred in Chicago, Wonderful Town, Cabaret and The Addams Family.

Brooke serves on the board of WIN, an organization dedicated to providing housing, services and programs to homeless women and children in NYC.

In her personal life, Brooke continues to be a strong advocate for women’s issues and keeping the arts alive in schools. She is the happily married mother of two beautiful daughters.

Pamela Shipley serves as Senior Vice President, Markets for Centene Corporation, a Fortune 500 company, a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. In her current role, she has oversight of the Health Plans: Georgia, New Hampshire, Ohio, Pennsylvania, and South Carolina. As well as current Interim CEO for Georgia.

Ms. Shipley, prior to her current role, was responsible for Strategy & Business Development for Envolve, a wholly-owned subsidiary of Centene Corporation that contracts with other healthcare and commercial organizations providing specialty services. Joining Centene in 2008, she led Payment Innovation, Provider Reimbursement, National Contracting, Provider Engagement and Contract Risk and Standardization for the organization leading an instrumental movement to Value Based Purchasing and Payment Innovation. Her additional responsibilities with Centene include leading the Business Enterprise Implementation group, and the Configuration Business Unit and she was the Plan President and CEO for Centene’ s Mississippi Health Plan, Magnolia.

Ms. Shipley has over 23 years of experience in Medicaid Managed Care. Prior to joining Centene, she led the Project Management Office, Medicaid implementation and held numerous other senior positions including Network Integration, Operations, and Customer Service at United Healthcare.

She is a member of Women Business Leaders, senior women executives in Healthcare. A native of Pennsylvania, Ms. Shipley attended Villanova University and received her B.S. from Chestnut Hill College in Philadelphia. She is married with nine children and currently resides in St. Louis, Missouri.

Robin L. Smith, M.D., MBA, is a business leader, entrepreneur, medical doctor and philanthropist. She received her Bachelor of Arts degree from Yale University and her M.D. degree from the Yale School of Medicine. Dr. Smith holds an MBA degree from the Wharton School of Business and completed the Stanford University Directors Program. In 2019, Dr. Smith received an honorary Doctor of Science degree from Thomas Jefferson Medical College. She is a trailblazer in the fields of regenerative medicine and predictive analytics and has focused on turnarounds, M&A and disruptive innovations driving interest and growth.

Dr. Smith is the founder, president and chairman of the board of the Cura Foundation and Stem for Life having served since 2008. She had also served as vice president and director of the Vatican’s Science and Faith (STOQ) Foundation for the last 6 years. Dr. Smith is a member of the executive board of trustees of Sanford Health, the board of overseers of the New York University Langone Medical Center in New York, and a board member of the Alliance for Cell Therapy Now and OPA Health. She is active in the NFL Alumni Association’s Regenerative Medicine and Cell Therapy initiative and is a member of the medical advisory committee at NFL Alumni Health. Dr. Smith was previously on Sanford Health’s International Board and the board of trustees of the New York University Langone Medical Center. She was also chairman of the board of directors of the New York University Hospital for Joint Diseases and served on the board of the Alliance for Regenerative Medicine (ARM) Foundation.

Dr. Smith has also extensively served on public companies’ boards and board committees. She is currently on the boards of directors of Celularity Inc (NASDAQ: CELU), a Celgene spin-out focused on cancer and regenerative medicine, Western Acquisition Ventures Corp. (NASDAQ: WAVS), as well as the private companies Spiritus Therapeutics and Vcinity Inc.

Dr. Smith co-authored Cells Are the New Cure (2017) and The Healing Cell: How the Greatest Revolution in Medical History Is Changing Your Life (2013). She was appointed as clinical associate professor, Department of Medicine, Rutgers New Jersey Medical School in 2017. She has also been widely recognized for her leadership in health care and as a female entrepreneur.

Garen is Founder/Chairman of ONE MIND (“OM”) a non-profit: (1) pursuing discoveries in brain health research fostering open science principles; (2) advancing better diagnostics, treatments, early intervention; and (3) eliminating the stigma for all brain illnesses. OM leverages large scale public/private partnerships as well as individual scientists to achieve these goals. Over 25 years, OM and the Staglin Music Festival for Brain Health have raised $450M for brain health.  OM and the National Academy of Medicine are leading the $10 Billion Healthy Brains Financing Initiative in collaboration with the World Bank, WHO, the Wellcome Trust and other global leaders. Garen is on the Board of SVB, Chairman of ExL Services and Profit Velocity Solutions, is a Senior Advisor to FTV Capital, and Co-Chairs the $5.2B UCLA Centennial Campaign. He and his family founded Staglin Family Vineyard in 1985 in Napa. The Staglins' motto is "Great Wine for Great Causes." They have generated over $1B through causes they have led, their charity, and wine donations.

Dr. Rudolph Tanzi is an internationally renowned neuroscientist, author and musician. His scientific expertise is in Alzheimer’s disease and brain health. He serves as Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, and Co-Director of the Henry and Allison McCance Center for Brain Health at Massachusetts General Hospital. He is also the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School.

Dr. Tanzi received his B.S. (microbiology) and B.A. (history) at the University of Rochester in 1980 and his Ph.D. (neurobiology) at Harvard Medical School in 1990. He is one of the world’s leading scientists in research aimed at preventing and treating Alzheimer’s disease. His research studies and books have also focused on preserving and promoting brain health. In his research achievements, Dr. Tanzi served on the team that was the first to find a disease gene ((Huntington’s disease) using human genetic markers, helping to launch the field of neurogenetics. Dr. Tanzi went on to identify all three early-onset familial Alzheimer’s disease genes: the amyloid precursor protein and presenilins 1 and 2. As leader of the Cure Alzheimer’s Fund Alzheimer’s Genome Project, he has identified several other Alzheimer’s disease genes, including the first shown to causing neuroinflammation in Alzheimer’s disease (CD33). Dr. Tanzi also discovered the Wilson’s disease gene and several other neurological disease genes.

Dr. Tanzi and his team have used Alzheimer’s genes and human stem cells to create “Alzheimer’s-in-a-Dish” - a three-dimensional human stem cell-derived neural culture system that was the first to recapitulate both pathological hallmarks of Alzheimer’s disease: plaques and tangles. This model has made drug screening for Alzheimer’s disease considerably faster and more effective. Using this system, Dr. Tanzi has developed several novel therapies for AD including gamma secretase modulators aimed at plaque pathology. These promising drugs are now heading into clinical trials in Alzheimer’s disease. Most recently, Dr. Tanzi and his team have discovered that beta-amyloid, the main component of senile plaques, may play a role in the innate immune system of the brain operating as an anti-microbial peptide, suggesting a possible role for infection in the etiology and pathogenesis of AD.

Dr. Tanzi has published over 500 research papers and has received the highest awards in his field, including the Metropolitan Life Foundation Award, Potamkin Prize, Ronald Reagan Award, Silver Innovator Award, and the Smithsonian American Ingenuity Award, the top national award for invention and innovation. He serves on dozens of editorial boards and scientific advisory boards and was named to TIME magazine’s list of TIME100 Most Influential People in the World. He also co-authored the books Decoding Darkness, and the three international bestsellers, Super Brain, Super Genes, and The Healing Self. Dr. Tanzi is also a musician who professionally records and performs (keyboards), most recently with Joe Perry and Aerosmith.

Mr. Rasesh “Sesh” Thakkar serves as Senior Managing Director of Tavistock Group and has been with the Group for 25+ years. Mr. Thakkar’s areas of experience ranges across industries such as life sciences, financial services, real estate, and leisure services as well as corporate finance and structures, mergers and acquisitions, strategic planning and operations. He’s also known for being one of the main visionaries behind Lake Nona.

Currently, he serves on the Board and Governors Council of the Orlando Economic Partnership. He is also on the Board of Directors of GuideWell Mutual Holding Corporation and TECO Energy and is a member of the Board of Trustees of the Tavistock Foundation and the Florida Governor’s Council of 100.

Daryl Tol is president and CEO of the Central Florida Division of AdventHealth. In this role, he leads the 21-campus division spread across seven counties in Central Florida.

The Central Florida Division sees more than two million patient visits per year, and its care network in the region also includes more than 30 CentraCare urgent-care centers; dozens of sports-medicine and rehab and imaging centers; and hundreds of physicians, ranging from primary care to a full spectrum of specialties. AdventHealth Orlando, the system’s flagship campus, was recognized as the No. 1 hospital in Florida by U.S. News & World Report in its 2019- 20 best hospital rankings.

Under Daryl’s leadership, AdventHealth has built on its legacy of innovation, embarking on partnerships with industry leaders including GE Healthcare and Moffitt Cancer Center. At the AdventHealth Research Institute, groundbreaking discoveries are being made in areas such as cancer, neuroscience, and metabolism and diabetes.

Prior to leading the Central Florida Division of AdventHealth, Daryl served in a variety of leadership roles, including regional chief executive for the five AdventHealth hospitals in Volusia and Flagler counties.

The Central Florida Division serves as the hub of the only national health care organization headquartered in Florida. Nationally, AdventHealth has more than 80,000 skilled and compassionate caregivers in physician practices, hospitals, outpatient clinics, skilled nursing facilities, home health agencies and hospice centers providing individualized, wholistic care at the system's nearly 50 hospital campuses and hundreds of care sites in diverse markets throughout almost a dozen states.

Daryl earned a master's degree in health administration from Loma Linda University, and a bachelor’s degree in business administration from Walla Walla University. He is involved in numerous community organizations, including as a trustee of the Florida Hospital Association, and as vice chair of the Orlando Economic Partnership Governor’s Council.

Daryl and his wife Stacey are the parents of three children, including twins. The family resides in Winter Park.

As the Administrator of the Centers for Medicare & Medicaid Services, Seema Verma oversees a $1 trillion budget, representing 26% of the total federal budget, and administers health coverage programs for more than 130 million Americans. She was nominated by President Trump on November 29, 2016 – the seventh nomination by the President-elect – and confirmed by the U.S. Senate on March 13, 2017.
 
The Administrator has set a bold agenda to empower patients and transform the healthcare system to deliver better value and results for patients through competition and innovation. CMS will focus all of its efforts on 16 strategic initiatives across Medicare, Medicaid, and the Exchanges to move the healthcare delivery system toward value.

Administrator Verma is a graduate of the University of Maryland, and holds a Master’s degree in Public Health with a concentration in health policy and management from Johns Hopkins University. Her editorial commentaries have appeared in the Wall Street Journal, Washington Post, Washington Times, and Health Affairs, and she also previously served as Vice President of Planning for the Health & Hospital Corporation of Marion County, Indiana. Most recently before heading CMS, she was President and CEO of SVC, Inc.

Nora Volkow is currently Director of the National Institute on Drug Abuse at the NIH. Over the past 30 years, she has published more than 770 peer-reviewed articles, more than 95 book chapters, edited four books on brain imaging and addiction and co-edited an Encyclopedia on Neuroscience. She has received multiple awards including membership in the National Academy of Medicine in 2000, the International Prize for Science from the French Institute of Health and Medical Research in 2009. She was named one of Time magazine’s “Top 100 People Who Shape Our World”,  “One of 20 People to Watch”, by Newsweek magazine, and “Innovator of the Year” by U.S. News & World Report. Her work as a researcher and as a leader has been instrumental in transforming the paradigm of drug addiction from that of a behavioral choice to that of a treatable brain disease.

Dr. James N. Weinstein is the Senior Vice President, Microsoft Healthcare, Head of Innovation and Health Equity. He is the immediate past Chief Executive Officer and President of Dartmouth-Hitchcock Health. Dr. Weinstein is currently a Clinical Professor in the Northwestern Kellogg Business School as well as a senior fellow at the Tuck School of Business. He is Editor-in-Chief of SPINE and author of the book "Unraveled: Prescriptions to Repair a Broken Health Care System". Dr. Weinstein held the Peggy Y. Thomson Chair in the Evaluative Clinical Sciences at the Geisel School of Medicine at Dartmouth. He co-founded and led the National High Value Health Care Collaborative, including 70 million patients and 70,000 physicians. He is a member of the National Academy of Medicine and serves on the organization’s Board for Population Health and Public Health Practice.

Michelle A. Williams, SM ’88, ScD ’91, is a renowned epidemiologist, an award-winning educator, and a widely recognized academic leader. She recently stepped down as Dean of the Faculty at the Harvard T.H. Chan School of Public Health after seven years, and is currently spending a sabbatical year as a Visiting Professor at Stanford University. Following her sabbatical, she will return to the Harvard Chan School as the Joan and Julius Jacobson Professor of Epidemiology and Public Health. Prior to becoming Dean, she was Professor and Chair of the Department of Epidemiology at the Harvard Chan School and Program Leader of the Population Health and Health Disparities Research Programs at Harvard’s Clinical and Translational Sciences Center.

Dr. Williams previously had a distinguished career at the University of Washington School of Public Health. Her research places special emphasis in the areas of reproductive, perinatal, pediatric, and molecular epidemiology. Dr. Williams has published more than 520 scientific articles and was elected to the National Academy of Medicine in 2016. In 2020, she was awarded the Ellis Island Medal of Honor and recognized by PR Week as one of the top 50 health influencers of the year. Dr. Williams has an undergraduate degree in biology and genetics from Princeton University, a master’s in civil engineering from Tufts University, and master’s and doctoral degrees in epidemiology from the Harvard Chan School.

Montel Williams is the host of the hit Lifetime shows Military Makeover and Operation Careers. Williams was the host and executive producer of the nationally syndicated The Montel Williams Show from 1991- 2008 and was awarded a Daytime Emmy for Outstanding Talk Show Host in 1996. Williams has authored eight books, four of which rose to NYT bestseller status. He was born and raised in the Baltimore, MD area and graduated from the United States Naval Academy in 1980. Williams served in both the Marines and Navy for a total of 22 years and is the recipient of several military awards and commendations. He currently serves on the board of directors for the Fisher House Foundation and the Anne Romney Center for Neurological Diseases at Brigham & Women’s Hospital.

Russell Wilson’s dedication to excellence is exemplified as an elite quarterback in the NFL, an innovated entrepreneur, and community leader. Growing up in VA, Wilson developed a love for football at a young age. His determination through high school and college led to being drafted by the Seattle Seahawks in 2012. Wilson has led his team to more wins in NFL history in his first eight seasons, including a Super Bowl win in 2013. Off the field, Russell’s leadership, passion and business acumen have resulted in assembling an impressive and diverse portfolio of business ventures. Wilson also heads Seattle-based West2East, a brand management, creative content and production company, in addition to Why Not You Productions, with Ciara, which focuses on scripted and unscripted film, television, and digital content projects. He has landed major endorsements and global ambassadorships with several companies including Nike, Microsoft, Wilson’s Sporting Goods, Alaska Airlines, Bose and Braun; and he founded a men’s apparel line, Good Man Brand. In 2014, he launched the Why Not You Foundation, a non-profit creating change by motivating and empowering youth. The WNYF raised over $4mil, including $2.6mil for Strong Against Cancer with Safeway. His weekly visits to Seattle Children’s lifts the spirits and brings joy to the hearts of patients and families.

Charles Woodson is a former football player, current television analyst, husband and father. He played college football for Michigan, where he led the Wolverines to a national championship in 1997 and won the Heisman in the same year. To date, he is the only primarily defensive player to win the Heisman. He was inducted into the College Football Hall of Fame in 2018.

Woodson was drafted by the Oakland Raiders fourth overall in the 1998 NFL Draft and was selected as the NFL Defensive Rookie of the Year. He was named to the Pro Bowl nine times, was the NFL Defensive Player of the in 2009 and won Super Bowl XLV (45) with the Green Bay Packers. After 18 years in the NFL, Woodson joined ESPN as an analyst in 2016 for three years and is currently working with FOX.

Through his foundation, The Charles Woodson Clinical Research Initiative (CWCRF) supports physician-scientists and research investigators whose work is in its earliest stages of development for impact and innovation. Woodson's initiative allows C.S. Mott Children's Hospital to award grants to support critical research projects that show promise of significant improvements in kids’ quality of life and longevity.

Additionally, The Charles C. Woodson Scholarship provides four years of support to an incoming freshman who has financial need and shows outstanding promise in the field of kinesiology. The initiative gives preference to entering kinesiology undergraduates from all the communities where Woodson has played football. That includes Detroit and Ann Arbor, Oakland, California, and Green Bay, Wisconsin, as well as his hometown of Fremont, Ohio.

A mother, an actress, an activist, a speaker, and a meditation teacher with a long-standing humanitarian engagement. A co-founder of the Never Alone, suicide prevention and mental wellbeing initiative of The Chopra Foundation. A movement that reduces mental health stigma and democratizes access to mental health hygiene tools. A Global Goodwill Ambassador to Skypower and the Honorary President of a grassroots charity in Myanmar. Wright lent her voice to UN Women and the UN Trust Fund to End Violence against Women.

Wright is the innovator of the Mental Hygiene Toolkit, a collection of mind cleansing and self-awareness tools to help individuals nurture their bodies, minds, and spirits, and develop inner guidance to consciously choose the best path for their lives. She has been a long-life student of Tibetan Buddhism and Vedanta.

Wright's acting and humanitarian projects bring her closer to understanding human nature and what binds consciousness to reality. She is the founder of the production company Conscious Intent, which supports different media formats to promote the human story. Her recent projects include "I Am Never Alone," which is the impetus for the Never Alone campaign with Dr. Deepak Chopra, Michael Beckwith, Temple Hayes directed by Michel Pascal.

As a motivational speaker, Wright has participated in numerous events, talk shows, podcasts, and social media outlets. Her recent engagements include UN Women conventions in London and Los Angeles, the First UN Trust Fund Grantee Convention in Bosnia and Herzegovina, the Difficult Dialogues forum in India, a suicide prevention seminar, and the Lake Nona Impact Forum. She is the annual host and co-founder of the Never Alone Summit, which features over 100+ speakers who share their strength and resilience tools in the mental health space.

Dr Vonda Wright, MD, MS is a double boarded Orthopaedic Sports Surgeon, Author, Researcher, Innovator and internationally recognized authority on active longevity and mobility harnessing innovative technology to provide integrative patient centered orthopedic sports surgery and wellness programming including her newest program, Precision Longevity. Dr Wright speaks worldwide, has written 5 books and is a frequent expert media contributor. A long time participant and speaker in the Lake Nona Impact Forum, Dr Wright moved her orthopedic practice to Lake Nona where she currently serves as the President of Hughston Orthopaedics SE, responsible for development and expansion of comprehensive integrated musculoskeletal care in the state of Florida, previously served as the inaugural medical director of the UPMC Lemieux Sports Complex, a 185,000 sqft joint venture between UPMC and the Pittsburgh Penguins and was the inaugural Chief of the Northside Orthopedic Institute Sports Medicine building an orthopedic surgery department serving Atlanta. In addition to her clinical practice Dr Wright has served as the lead team doctor for multiple Division I college teams, professional athletes, the players doctor for several PGA US open and tour championships as well as the athletes of the Atlanta and Pittsburgh Ballet Theaters. Dr Wright serves the communities she lives in as a member of multiple non-profit boards and lives with her husband, 2x Stanley Cup champion, Peter Taglianetti and family in Laureate Park.

Dr. George Yancopoulos is the Founding Scientist, President and Chief Scientific Officer of Regeneron, a leading biotechnology company. He received his M.D. and Ph.D. from Columbia University. At Regeneron, Dr. Yancopoulos has built a robust portfolio of FDA-approved and investigational medicines, driven by Regeneron’s novel and proprietary technologies for target discovery and drug development.

Andrew J. Young has earned worldwide recognition as a pioneer in and champion of civil and human rights. Ambassador Young’s lifelong dedication to service is illustrated by his extensive leadership experience of over sixty-five years, serving as a member of Congress, African American U.S. Ambassador to the United Nations, Mayor of Atlanta, and ordained minister, among other positions.

During the 1960s, Young was a key strategist and negotiator during civil rights campaigns that led to the passage of the Civil Rights Act of 1964 and the Voting Rights Act of 1965. Appointed as an Ambassador to the United Nations in 1977, Young negotiated an end to white-minority rule in Namibia and Zimbabwe and brought President Carter's emphasis on human rights to international diplomacy efforts. As two-term Mayor of Atlanta, Young brought in over 1,100 businesses, over 70 billion in foreign direct investments and generated over a million jobs.

Ambassador Young has received honorary degrees from more than 100 universities and colleges in the U.S. and abroad and has received various awards, including an Emmy Lifetime Achievement award in 2011 and the Dan Sweat Award in 2017. His portrait also became part of the permanent collection of the Smithsonian National Portrait Gallery.

Ambassador Young also serves on a number of boards, including, but not limited to, the Martin Luther King Center for Non-Violent Social Change, Morehouse College, Andrew Young School of Policy Studies at Georgia State and Americas Mart. In 2003, he and his wife Carolyn McClain Young founded the Andrew J. Young Foundation to support and promote education, health, leadership and human rights in the U.S., Africa, and the Caribbean. Young currently serves as the Chairman of the Andrew J. Young Foundation.

In 2012, Young retired from GoodWorks International, LLC, after well over a decade of facilitating sustainable economic development in the business sectors of the Caribbean and Africa. Young was born in 1932 in New Orleans, and he currently lives in Atlanta with his wife, Carolyn McClain. He is also a father of three daughters and one son, a grandfather of nine and a great grandfather on one.